These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

588 related items for PubMed ID: 26663909

  • 1. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
    Wu L, Qin Y, Xia S, Dai M, Han X, Wu Y, Zhang X, Ma J, Wang Y, Tang Y, Liu Z, Zhu W, Jallal B, Yao Y, Qu B, Shen N.
    Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
    [Abstract] [Full Text] [Related]

  • 2. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
    Wu L, Jiang X, Qi C, Zhang C, Qu B, Shen N.
    Front Immunol; 2021 May; 12():653989. PubMed ID: 33868295
    [Abstract] [Full Text] [Related]

  • 3. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP, Sagalovskiy I, Guo Q, Nezos A, Kapsogeorgou EK, Lu P, Liang Zhou J, Kirou KA, Seshan SV, Moutsopoulos HM, Crow MK.
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [Abstract] [Full Text] [Related]

  • 4. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
    Feng X, Chen W, Xiao L, Gu F, Huang J, Tsao BP, Sun L.
    Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
    [Abstract] [Full Text] [Related]

  • 5. Potential role of RhoA GTPase regulation in type interferon signaling in systemic lupus erythematosus.
    Fan W, Wei B, Chen X, Zhang Y, Xiao P, Li K, Zhang YQ, Huang J, Leng L, Bucala R.
    Arthritis Res Ther; 2024 Jan 20; 26(1):31. PubMed ID: 38243295
    [Abstract] [Full Text] [Related]

  • 6. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA, Huijser E, van Helden-Meeuwsen CG, Tas L, Huizinga R, Dalm VASH, van Hagen PM, Groot N, Kamphuis S, van Daele PLA, Versnel MA.
    J Autoimmun; 2018 Jul 20; 91():97-102. PubMed ID: 29673738
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.
    Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X, Zhou H, de Vries N, Tak PP, Chen S, Shen N.
    Arthritis Rheum; 2009 Apr 20; 60(4):1065-75. PubMed ID: 19333922
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of Renal Hsa-miR-127-3p Contributes to the Overactivation of Type I Interferon Signaling Pathway in the Kidney of Lupus Nephritis.
    Wu L, Han X, Jiang X, Ding H, Qi C, Yin Z, Xiao J, Xiong L, Guo Q, Ye Z, Qu B, Shen N.
    Front Immunol; 2021 Apr 20; 12():747616. PubMed ID: 34745118
    [Abstract] [Full Text] [Related]

  • 9. Identification of Renal Long Non-coding RNA RP11-2B6.2 as a Positive Regulator of Type I Interferon Signaling Pathway in Lupus Nephritis.
    Liao Z, Ye Z, Xue Z, Wu L, Ouyang Y, Yao C, Cui C, Xu N, Ma J, Hou G, Wang J, Meng Y, Yin Z, Liu Y, Qian J, Zhang C, Ding H, Guo Q, Qu B, Shen N.
    Front Immunol; 2019 Apr 20; 10():975. PubMed ID: 31130957
    [Abstract] [Full Text] [Related]

  • 10. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.
    Karonitsch T, Feierl E, Steiner CW, Dalwigk K, Korb A, Binder N, Rapp A, Steiner G, Scheinecker C, Smolen J, Aringer M.
    Arthritis Rheum; 2009 May 20; 60(5):1463-71. PubMed ID: 19404947
    [Abstract] [Full Text] [Related]

  • 11. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y, Ewart D, Crabtree JN, Yamamoto A, Baechler EC, Fazeli P, Peterson EJ.
    Arthritis Rheumatol; 2015 Sep 20; 67(9):2403-14. PubMed ID: 26018863
    [Abstract] [Full Text] [Related]

  • 12. Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus Erythematosus.
    Qu B, Cao J, Zhang F, Cui H, Teng J, Li J, Liu Z, Morehouse C, Jallal B, Tang Y, Guo Q, Yao Y, Shen N.
    Arthritis Rheumatol; 2015 Dec 20; 67(12):3209-18. PubMed ID: 26315540
    [Abstract] [Full Text] [Related]

  • 13. Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses.
    Deng Y, Zheng Y, Li D, Hong Q, Zhang M, Li Q, Fu B, Wu L, Wang X, Shen W, Zhang Y, Chang J, Song K, Liu X, Shang S, Cai G, Chen X.
    EBioMedicine; 2021 Aug 20; 70():103477. PubMed ID: 34284174
    [Abstract] [Full Text] [Related]

  • 14. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC, Zhou QL, Li XZ, Yang JH, Ao X, Veeraragoo P, Zuo XX.
    Cytokine; 2011 Mar 20; 53(3):295-300. PubMed ID: 21163672
    [Abstract] [Full Text] [Related]

  • 15. High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass Cytometry.
    Yiu G, Rasmussen TK, Tsai BL, Diep VK, Haddon DJ, Tsoi J, Miller GD, Comin-Anduix B, Deleuran B, Crooks GM, Utz PJ.
    Front Immunol; 2022 Mar 20; 13():833636. PubMed ID: 35185925
    [Abstract] [Full Text] [Related]

  • 16. Identification of LncRNA Linc00513 Containing Lupus-Associated Genetic Variants as a Novel Regulator of Interferon Signaling Pathway.
    Xue Z, Cui C, Liao Z, Xia S, Zhang P, Qin J, Guo Q, Chen S, Fu Q, Yin Z, Ye Z, Tang Y, Shen N.
    Front Immunol; 2018 Mar 20; 9():2967. PubMed ID: 30619325
    [Abstract] [Full Text] [Related]

  • 17. The RhoA GTPase regulates Type I Interferon Signaling in Systemic lupus erythematosus.
    Fan W, Wei B, Chen X, Zhang Y, Xiao P, Li K, Zhang YQ, Huang J, Leng L, Bucala R.
    Res Sq; 2023 Sep 20. PubMed ID: 37790522
    [Abstract] [Full Text] [Related]

  • 18. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
    Kaga H, Komatsuda A, Omokawa A, Ito M, Teshima K, Tagawa H, Sawada K, Wakui H.
    Mod Rheumatol; 2015 Sep 20; 25(6):865-70. PubMed ID: 25775145
    [Abstract] [Full Text] [Related]

  • 19. Prion-like Aggregation of Mitochondrial Antiviral Signaling Protein in Lupus Patients Is Associated With Increased Levels of Type I Interferon.
    Shao WH, Shu DH, Zhen Y, Hilliard B, Priest SO, Cesaroni M, Ting JP, Cohen PL.
    Arthritis Rheumatol; 2016 Nov 20; 68(11):2697-2707. PubMed ID: 27110677
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-10 receptor expression and signalling were down-regulated in CD4⁺ T cells of lupus nephritis patients.
    Cui HD, Qi ZM, Yang LL, Qi L, Zhang N, Zhang XL, Du SY, Jiang Y.
    Clin Exp Immunol; 2011 Aug 20; 165(2):163-71. PubMed ID: 21635228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.